Electrochemotherapy in the Treatment of Kaposi Sarcoma Cutaneous Lesions: A Two-Center Prospective Phase II Trial
P. Curatolo(Sapienza University of Rome), Maria Grazia Bernengo(University of Turin), Monica Mancini(University of Insubria), Pietro Quaglino(Department of Medical Sciences), Stefano Calvieri(Sapienza University of Rome), Claudio Mortera(University of Turin), Federica Marenco(University Dermatology), Roberta Rotunno(Sapienza University of Rome), Tiziana Nardò(University of Turin)
Cited by 98
Related Papers
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas
|Journal of the American Academy of Dermatology|2002|493
Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression
|JAMA Dermatology|2015|452